We aim to discover new classes of antimicrobial compounds that are active against methicillin/multidrug resistant Staphylococcus aureus (MRSA). Currently, MRSA infections cause more deaths each year in the U.S. than HIV/AIDS, and existing therapies are failing. We have uncovered evidence that beta lactam resistance in MRSA, which is mediated in part by the expression of a gene (mecA) encoding a resistant transpeptidase (PBP2A), requires a functional wall teichoic acid (WTA) biosynthetic pathway. Based on this, we have hypothesized that small molecules that prevent the expression of WTAs by inhibiting the first enzyme in the WTA pathway (TarO) will render MRSA susceptible to beta lactams. Consistent with this hypothesis, preliminary studies have shown that tunicamycin, a natural product that selectively inhibits TarO, indeed sensitizes MRSA to methicillin. (Unfortunately, tunicamycin has eukaryotic toxicity.) Herein, we propose a set of genetic experiments to confirm that methicillin resistance requires the expression of anionic polymer WTAs. We plan to develop and carry out a high throughput screen to identify small molecules that render MRSA strains sensitive to methicillin. This will be done by screening the compounds in duplicate in both the presence and absence of methicillin. Compounds that kill MRSA strains only in the presence of low methicillin concentrations will be examined to assess whether they inhibit WTA biosynthesis. Several techniques will be used to validate hits, including testing for the presence of WTAs through phage infection and chemical extraction. We also have a small molecule available whose antibiotic activity is antagonized by TarO inhibitors, allowing for rapid testing of the most promising hits. Confirmed non-toxic WTA inhibitors would be candidates for evaluating the utility of combination therapy for treating MRSA infections and could also be used to assess whether such inhibitors delay the development of beta lactam resistance in susceptible S. aureus strains.

Public Health Relevance

Methicillin-resistant Staphylococcus aureus (MRSA) infections pose a large threat to public health in the United States, causing nearly 19,000 deaths in 2005. Polymers attached to the surface of S. aureus (wall teichoic acids, WTAs) are required for these bacteria to cause infections in patients. Compounds that stop WTA production could potentially serve as new therapeutics to combat MRSA.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32AI084316-02
Application #
7928782
Study Section
Special Emphasis Panel (ZRG1-F13-C (20))
Program Officer
Xu, Zuoyu
Project Start
2009-09-15
Project End
2011-06-30
Budget Start
2010-09-15
Budget End
2011-06-30
Support Year
2
Fiscal Year
2010
Total Cost
$39,432
Indirect Cost
Name
Harvard University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Ostash, Bohdan; Campbell, Jennifer; Luzhetskyy, Andriy et al. (2013) MoeH5: a natural glycorandomizer from the moenomycin biosynthetic pathway. Mol Microbiol 90:1324-38
Suzuki, Takashi; Campbell, Jennifer; Kim, Younghoon et al. (2012) Wall teichoic acid protects Staphylococcus aureus from inhibition by Congo red and other dyes. J Antimicrob Chemother 67:2143-51
Campbell, Jennifer; Singh, Atul K; Swoboda, Jonathan G et al. (2012) An antibiotic that inhibits a late step in wall teichoic acid biosynthesis induces the cell wall stress stimulon in Staphylococcus aureus. Antimicrob Agents Chemother 56:1810-20
Campbell, Jennifer; Singh, Atul K; Santa Maria Jr, John P et al. (2011) Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus. ACS Chem Biol 6:106-16
Suzuki, Takashi; Campbell, Jennifer; Swoboda, Jonathan G et al. (2011) Role of wall teichoic acids in Staphylococcus aureus endophthalmitis. Invest Ophthalmol Vis Sci 52:3187-92
Suzuki, Takashi; Swoboda, Jonathan G; Campbell, Jennifer et al. (2011) In vitro antimicrobial activity of wall teichoic acid biosynthesis inhibitors against Staphylococcus aureus isolates. Antimicrob Agents Chemother 55:767-74
Campbell, Jennifer (2011) High-throughput assessment of bacterial growth inhibition by optical density measurements. Curr Protoc Chem Biol 3:
Lee, Kyungae; Campbell, Jennifer; Swoboda, Jonathan G et al. (2010) Development of improved inhibitors of wall teichoic acid biosynthesis with potent activity against Staphylococcus aureus. Bioorg Med Chem Lett 20:1767-70